ResMed Current Ratio 2010-2025 | RMD

Current and historical current ratio for ResMed (RMD) from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. ResMed current ratio for the three months ending March 31, 2025 was 3.41.
ResMed Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2025-03-31 $3.21B $0.94B 3.41
2024-12-31 $2.84B $0.85B 3.33
2024-09-30 $2.64B $0.90B 2.92
2024-06-30 $2.36B $0.91B 2.59
2024-03-31 $2.35B $0.77B 3.04
2023-12-31 $2.38B $0.76B 3.11
2023-09-30 $2.31B $0.77B 2.99
2023-06-30 $2.37B $0.76B 3.12
2023-03-31 $2.34B $0.76B 3.07
2022-12-31 $2.33B $0.73B 3.17
2022-09-30 $2.03B $0.69B 2.94
2022-06-30 $1.93B $0.69B 2.80
2022-03-31 $1.70B $0.67B 2.55
2021-12-31 $1.55B $0.62B 2.49
2021-09-30 $1.59B $0.62B 2.54
2021-06-30 $1.58B $0.91B 1.73
2021-03-31 $1.47B $0.88B 1.67
2020-12-31 $1.45B $0.58B 2.51
2020-09-30 $1.54B $0.59B 2.61
2020-06-30 $1.52B $0.60B 2.53
2020-03-31 $1.47B $0.55B 2.67
2019-12-31 $1.30B $0.50B 2.60
2019-09-30 $1.16B $0.55B 2.11
2019-06-30 $1.15B $0.56B 2.06
2019-03-31 $1.10B $0.46B 2.38
2018-12-31 $1.06B $0.44B 2.44
2018-09-30 $1.09B $0.42B 2.58
2018-06-30 $1.07B $0.51B 2.09
2018-03-31 $1.60B $0.46B 3.48
2017-12-31 $1.75B $1.36B 1.29
2017-09-30 $1.66B $0.35B 4.72
2017-06-30 $1.64B $0.36B 4.57
2017-03-31 $1.61B $0.34B 4.77
2016-12-31 $1.52B $0.68B 2.23
2016-09-30 $1.48B $0.62B 2.38
2016-06-30 $1.42B $0.64B 2.23
2016-03-31 $1.40B $0.29B 4.89
2015-12-31 $1.35B $0.27B 5.09
2015-09-30 $1.53B $0.26B 5.96
2015-06-30 $1.41B $0.27B 5.28
2015-03-31 $1.55B $0.26B 6.06
2014-12-31 $1.56B $0.26B 6.00
2014-09-30 $1.54B $0.25B 6.04
2014-06-30 $1.56B $0.27B 5.77
2014-03-31 $1.56B $0.25B 6.33
2013-12-31 $1.56B $0.24B 6.44
2013-09-30 $1.56B $0.61B 2.55
2013-06-30 $1.45B $0.57B 2.52
2013-03-31 $1.58B $0.58B 2.72
2012-12-31 $1.53B $0.25B 6.09
2012-09-30 $1.45B $0.25B 5.73
2012-06-30 $1.36B $0.25B 5.38
2012-03-31 $1.33B $0.26B 5.15
2011-12-31 $1.25B $0.23B 5.46
2011-09-30 $1.14B $0.23B 5.06
2011-06-30 $1.29B $0.21B 6.19
2011-03-31 $1.20B $0.19B 6.28
2010-12-31 $1.15B $0.25B 4.64
2010-09-30 $1.07B $0.29B 3.73
2010-06-30 $0.99B $0.31B 3.15
2010-03-31 $1.03B $0.33B 3.17
2009-12-31 $0.93B $0.24B 3.86
2009-09-30 $0.94B $0.29B 3.22
2009-06-30 $0.85B $0.27B 3.17
2009-03-31 $0.73B $0.23B 3.19
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $36.801B $4.685B
ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $232.094B 27.91
Boston Scientific (BSX) United States $148.004B 37.05
Stryker (SYK) United States $145.912B 30.51
EssilorLuxottica (ESLOY) France $130.051B 0.00
Medtronic (MDT) Ireland $112.158B 15.90
Lonza Group Ag (LZAGY) Switzerland $50.407B 0.00
Haleon (HLN) United Kingdom $48.971B 27.90
Agilent Technologies (A) United States $33.162B 21.62
GE HealthCare Technologies (GEHC) United States $32.817B 15.58
Terumo (TRUMY) Japan $26.665B 34.63
Koninklijke Philips (PHG) Netherlands $22.070B 15.86
Insulet (PODD) United States $21.511B 84.44
Zimmer Biomet Holdings (ZBH) United States $18.366B 11.80
Baxter (BAX) United States $15.831B 11.82
Smith & Nephew SNATS (SNN) United Kingdom $13.086B 0.00
Sunny Optical Technology (SNPTF) China $9.076B 0.00
Demant (WILYY) Denmark $8.854B 0.00
Bio-Rad Laboratories (BIO) United States $6.138B 21.36
Lantheus Holdings (LNTH) United States $5.758B 14.52
Prestige Consumer Healthcare (PBH) United States $4.234B 18.91
Perrigo (PRGO) Ireland $3.598B 9.12
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.442B 15.68
ICU Medical (ICUI) United States $3.353B 24.73
Envista Holdings (NVST) United States $3.224B 26.79
GN Store Nord (GNNDY) Denmark $2.180B 18.06
QuidelOrtho (QDEL) United States $2.043B 14.05
LeMaitre Vascular (LMAT) United States $1.883B 42.08
AtriCure (ATRC) United States $1.692B 0.00
Acuren (TIC) United States $1.348B 0.00
Neogen (NEOG) United States $1.198B 15.33
AdaptHealth (AHCO) United States $1.190B 12.08
BioLife Solutions (BLFS) United States $1.132B 0.00
Kestra Medical Technologies (KMTS) United States $1.087B 0.00
Green Thumb Industries (GTBIF) United States $1.082B 24.33
Phibro Animal Health (PAHC) United States $0.982B 12.55
InMode (INMD) Israel $0.920B 9.27
CeriBell (CBLL) United States $0.644B 0.00
Evolus (EOLS) United States $0.622B 0.00
Owens & Minor (OMI) United States $0.613B 5.08
Capricor Therapeutics (CAPR) United States $0.611B 0.00
Curaleaf Holdings (CURLF) Canada $0.581B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.581B 0.00
Valneva SE (VALN) France $0.517B 0.00
Surmodics (SRDX) United States $0.417B 0.00
Tilray Brands (TLRY) Canada $0.413B 0.00
VAREX IMAGING (VREX) United States $0.351B 12.91
SNDL (SNDL) Canada $0.349B 0.00
Aurora Cannabis (ACB) Canada $0.327B 58.20
Canopy Growth (CGC) Canada $0.298B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.291B 0.00
Cerus (CERS) United States $0.281B 0.00
Viemed Healthcare (VMD) United States $0.272B 22.90
Cresco Labs (CRLBF) United States $0.263B 0.00
ZimVie (ZIMV) United States $0.261B 11.89
Sanara MedTech (SMTI) United States $0.258B 0.00
Sanuwave Health (SNWV) United States $0.258B 0.00
Omeros (OMER) United States $0.221B 0.00
Biote (BTMD) United States $0.215B 6.05
OraSure Technologies (OSUR) United States $0.214B 0.00
TriSalus Life Sciences (TLSI) United States $0.212B 0.00
Brainsway (BWAY) Israel $0.208B 55.05
Quanterix (QTRX) United States $0.196B 0.00
High Tide (HITI) Canada $0.191B 0.00
Utah Medical Products (UTMD) United States $0.185B 15.08
Organigram Global (OGI) Canada $0.185B 0.00
Verano Holdings (VRNOF) United States $0.184B 0.00
Exagen (XGN) United States $0.153B 0.00
FitLife Brands (FTLF) United States $0.133B 16.40
Vireo Growth (VREOF) United States $0.129B 0.00
Jin Medical (ZJYL) China $0.107B 0.00
MacroGenics (MGNX) United States $0.103B 0.00
Veru (VERU) United States $0.095B 0.00
Quipt Home Medical (QIPT) United States $0.094B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Fonar (FONR) United States $0.089B 11.50
TerrAscend (TSNDF) Canada $0.083B 0.00
Agape ATP (ATPC) $0.075B 0.00
InterCure (INCR) Israel $0.069B 0.00
Cytosorbents (CTSO) United States $0.068B 0.00
Zynex (ZYXI) United States $0.066B 0.00
Apyx Medical (APYX) United States $0.065B 0.00
Jushi Holdings (JUSHF) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.058B 0.00
Modular Medical (MODD) United States $0.044B 0.00
Nephros (NEPH) United States $0.040B 54.43
United-Guardian (UG) United States $0.038B 13.25
Rockwell Medical (RMTI) United States $0.035B 0.00
Safety Shot (SHOT) United States $0.020B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
Cellectar Biosciences (CLRB) United States $0.016B 0.00
INLIF (INLF) $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00